Table 3.
Intravenous antibiotics versus each other for acute pyelonephritis: results of RCTs (see text)
First antibiotic | Total number of people | Early cure* rates % | Late cure* rates % | Comparator antibiotic | Early Cures/ Total (%) | Late Cures/ Total (%) |
Piperacillin 2 g plus Tazobactam 0.5 gthree times daily for 5–14 days | 40 | NA | 58 | Imipenem 0.5 g plus cilastatin 0.5 gthree times daily for 5–14 days | NA | 49 |
Isepamicin 8–15 mg daily for 4–14 days | 60 | NA | 91 | Amikacin 7.5 mg/kg twice daily for 4–14 days | NA | 93 |
Co-amoxiclav 2.2 g three times daily (duration not specified) | 48 | 85 | NA | Gentamicin 1.5 mg/kg as single dose plusamoxicillin 2.2 g three times daily for 7–14 days | 100 | NA |
*Early cure: negative urine culture within 7–10 days of starting treatment; late cure: negative urine culture 2–4 weeks or more after stopping treatment. NA, not available; P values not available. Piccoli GB, Consiglio V, Colla L, Mesiano P, Magnano A, Burdese M, Marcuccio C, Mezza E, Veglio V, Piccoli G. Antibiotic treatment for acute ‘uncomplicated’ or ‘primary’ pyelonephritis: a systematic, ‘semantic revision’. Int J Antimicrob Agents. 2006;28S S49–S63